Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 11,850.00
Ask: 12,300.00
Change: 0.00 (0.00%)
Spread: 450.00 (3.797%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,190.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Spain limits AstraZeneca coronavirus vaccine to over 60-year olds

Wed, 07th Apr 2021 23:14

(Recasts to focus on AstraZeneca)

MADRID, April 7 (Reuters) - Spain will only give
AstraZeneca's coronavirus vaccine to people over 60 years old
after European and British regulators found a potential link
between the shot and rare brain blood clots.

"The vaccination strategy is changing and from tomorrow only
over 60-year-olds will be vaccinated with AstraZeneca," Health
Minister Carolina Darias told a news conference late on
Wednesday following a meeting of regional health chiefs.

Darias said a decision would be taken on Thursday on whether
to administer the second round of the vaccine to people who had
already received their first dose.

The European Medicines Agency announced earlier it had
reports of 169 cases of the rare clotting disorder out of 34
million doses administered within Europe, roughly one for every
100,000 people under 60 vaccinated. Most occurred in women under
60 and within two weeks of injection. [nL1N2M01J1

Maria Jesus Lamas, director of Spain's drug regulator, said
that number was higher than expected, though very small:
"Despite the rarity of these side effects, the modification to
the technical guidance is important," Lamas said.

A summit of European Union health ministers failed to agree
on common guidance for the vaccine and the EMA said countries
should set their own regulations.

Spain's decision follows Italy recommending the shot only
for those over 60 and Britain said people under 30 should get an
alternative.

People lining up for a shot in Madrid earlier on Wednesday
vented frustration at constantly changing guidance for the
vaccine, which is subject to a patchwork of different rules
governing its use.

"Today has been a very distressing day because of all the
news coming from the European Medicines Agency," said Carmen
Ruiz after coming out of Atletico Madrid's Wanda football
stadium, now converted into a vaccine centre.

Though Spain is faring better than neighbouring France,
where rampant infections have pushed hospital admittance rates
to near five-month highs, the daily caseload has been increasing
for three weeks.

The health ministry registered 8,788 new cases, bringing the
total to 3.33 million. The death toll rose by 126 to 76,037.

Wary that increased social contact over Easter could trigger
a full-blown fourth wave, authorities in Catalonia, the Basque
Country and Aragon imposed fresh restrictions on movement.

(Reporting by Clara-Laeila Laudette, Guillermo Martinez, Elena
Rodriguez, Nathan Allen and Joan Faus, editing by Andrei Khalip
and Grant McCool)

More News
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more
27 Nov 2023 16:12

London close: Stocks start week in subdued state

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

Read more
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more
20 Nov 2023 10:49

AstraZeneca launches new life sciences tech innovation firm Evinova

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes.

Read more
17 Nov 2023 15:20

London close: Stocks higher despite weaker retail sales data

(Sharecast News) - London's stock markets finished in a positive state on Friday despite weaker-than-expected UK retail sales figures.

Read more
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more
14 Nov 2023 10:51

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint.

Read more
14 Nov 2023 09:22

AstraZeneca's latest lung cancer trial fails its primary endpoint

(Sharecast News) - AstraZeneca announced on Tuesday that its 'PACIFIC-2' phase three trial for Imfinzi, or durvalumab, concurrently administered with chemoradiotherapy (CRT), did not achieve its primary endpoint of progression-free survival compared to CRT alone.

Read more
13 Nov 2023 09:45

LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Nov 2023 15:02

London close: Stocks gain as investors await Powell speech

(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair later in the global day.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.